Show simple item record

dc.contributor.authorOcama, Ponsiano
dc.contributor.authorFeld, Jordan J
dc.contributor.authorRonald, Allan
dc.date.accessioned2013-07-05T07:15:03Z
dc.date.available2013-07-05T07:15:03Z
dc.date.issued2005
dc.identifier.citationOcama, P., Feld, J.J., Ronald, A. (2005). The liver in HIV in Africa. Antiviral Therapy, 10en_US
dc.identifier.issn1359-6535
dc.identifier.urihttp://hdl.handle.net/10570/1716
dc.description.abstractAs access to antiretroviral therapy improves across the African continent, liver disease is emerging as an important cause of morbidity and mortality among HIV-infected individuals. Although coinfection with hepatitis B virus (HBV) and hepatitis C virus (HCV), along with highly active antiretroviral therapy (HAART)- induced hepatotoxicity appear to be the major causes of liver disease in this population, other diseases endemic to Africa with hepatic manifestations are influenced by HIV infection as well. In this review we present the available data on liver disease in HIV-infected populations in Africa and discuss relevant data from the rest of the world. In addition, we highlight important areas for further study.en_US
dc.language.isoenen_US
dc.publisherInternational Medical Pressen_US
dc.subjectHAARTen_US
dc.subjectAntiretroviral therapyen_US
dc.subjectHIV/AIDSen_US
dc.subjectAfricaen_US
dc.subjectMorbidityen_US
dc.subjectMortalityen_US
dc.subjectHepatitis B virus (HBV)en_US
dc.subjectHepatitis C virus (HCV)en_US
dc.subjectLiver diseaseen_US
dc.titleThe liver in HIV in Africaen_US
dc.typeJournal article, peer revieweden_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record